Evidence map›Paper›PMID 36613826›Full record

ArticleInternational journal of molecular sciences2022

Long-Chain and Medium-Chain Fatty Acids in Energy Metabolism of Murine Kidney Mitochondria.

Alexander V Panov, Vladimir I Mayorov, Anna E Dikalova, Sergey I Dikalov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Rethinking Human Energy Metabolism.Current issues in molecular biology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Phylogenetic Aspects of Higher Plant Lipid Fatty Acid Profile.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Ketone body mediated histone β-hydroxybutyrylation is reno-protective.bioRxiv : the preprint server for biology · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexander V PanovDepartment of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31201, USA.
Vladimir I MayorovDepartment of Biomedical Sciences, Mercer University School of Medicine, Macon, GA 31201, USA.
Anna E DikalovaDivision of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.
Sergey I DikalovDivision of Clinical Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232, USA.ORCID 0000-0003-2976-6184
Mercer University · USVanderbilt University Medical Center · US

Funding

Targeting Mitochondrial Cyclophilin D in Vascular Oxidative Stress and HypertensionR01HL144943 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DIKALOV, SERGEY · 2019 to 2022
$1.7M
Navicent Health Foundation grant Mercer University School of MedicineNIH HHS R01HL144943 and RO1HL157583
6 · The paper itself

Abstract

Scientists have long established that fatty acids are the primary substrates for kidney mitochondria. However, to date we still do not know how long-chain and middle-chain fatty acids are oxidized at the mitochondrial level. Our previous research has shown that mitochondria from the heart, brain, and kidney oxidize palmitoylcarnitine at a high rate only in the presence of succinate, glutamate, or pyruvate. In this paper, we report properties of the isolated kidney mitochondria and how malate and succinate affect the oxidation of C16 and C8 acylcarnitines. The isolated kidney mitochondria contain very few endogenous substrates and require malate to oxidize pyruvate, glutamate, and C16 or C8 acylcarnitines. We discovered that with 10 µM of C16 or C8 acylcarnitines, low concentrations of malate (0.2 mM) or succinate (0.5 mM) enhance the States 4 and 3 respiratory rates several times. The highest respiration rates were observed with C16 or C8 acylcarnitines and 5 mM succinate mixtures. Results show that kidney mitochondria, unlike the heart and brain mitochondria, lack the intrinsic inhibition of succinate dehydrogenase. Additionally, results show that the oxidation of fatty acid by the small respirasome's supercomplex generates a high level of CoQH2, and this makes SDH in the presence of succinate reverse the flow of electrons from CoQH2 to reduce fumarate to succinate. Finally, we report evidence that succinate dehydrogenase is a key mitochondrial enzyme that allows fast oxidation of fatty acids and turns the TCA cycle function from the catabolic to the anabolic and anaplerotic metabolic pathways.

Indexed as

MalatesSuccinate DehydrogenaseAnimalsCarnitineEnergy MetabolismFatty AcidsGlutamatesKidneyMiceMitochondriaOxidation-ReductionPyruvic AcidSuccinatesSuccinic AcidacylcarnitineCarnitineFatty AcidsGlutamatesMalatesmalic acidPyruvic AcidSuccinate DehydrogenaseSuccinatesSuccinic Acidbeta-oxidationfatty acidskidneykidney mitochondriaoctanoylcarnitineoxidative phosphorylationpalmitoylcarnitinerespirasomerespirationsuccinatesuccinate dehydrogenase

Identifiers

PMID36613826
PMCPMC9820327
OpenAlexW4313259759

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.